Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
4.92 CAD 0.16 ( 3.36%)
Last update at 2026-11-04T20:43:00Z
VOLUME
332444
Market Cap
1435.85M

Momentum Score

…

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
4.81
Low
4.98
High
52 Week Price Range
2.47
Low
4.66
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cronos Group Inc is a Canadian cannabis company that develops, cultivates and distributes adult-use and hemp-derived products through owned brands and manufacturing operations. Growth drivers include expansion of legalized markets, product innovation and a strategic investor relationship that may support scale. The company may appeal to investors seeking exposure to the legalized cannabis industry and potential upside from market liberalization.

Major risks include regulatory uncertainty, intense competition and margin pressure, execution and profitability challenges as the business scales, and reliance on partnerships and capital markets.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
4.76
Dividend Yield
-
Revenue TTM
146.59M
Revenue Per Share
0.38
Gross Profit TTM
58.40M
Debt / Equity
0.00
ROE
-0.26%
Net Debt
-787.68M
ROCE
-1.56%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -17.42M 36.55M -73.49M -134.56M -397.13M
Minority interest -6.52M 1.06M 0.59M 0.00M 1.10M
Net income -9.61M 41.04M -73.79M -168.73M -396.70M
Selling general administrative 70.81M 76.82M 58.23M 86.29M 106.63M
Selling and marketing expenses - - 22.70M 22.28M 44.94M
Gross profit 61.70M 30.45M 11.88M 11.97M -17.53M
Reconciled depreciation 14.23M 9.34M 8.11M 13.12M 15.40M
Ebit -17.84M -54.21M -79.72M -116.01M 6.79M
Ebitda -3.36M -45.37M -72.28M -59.19M 22.19M
Depreciation and amortization 14.48M 8.84M 7.44M 56.83M 15.40M
Operating income -17.84M -76.46M -84.60M -116.01M 6.79M
Other operating expenses 166.99M 193.96M 171.63M 207.92M 271.35M
Interest expense - - - 22.54M 0.03M
Tax provision -14.19M -3.44M -3.23M 34.17M -0.43M
Interest income 39.96M 138.51M 51.23M 52.16M 162.73M
Net interest income 39.96M 52.02M 51.23M 22.54M 9.07M
Extraordinary items - 0.00M -4.11M 0.00M -0.50M
Income tax expense -14.44M -3.44M -3.23M 34.17M -0.43M
Total revenue 149.15M 117.50M 87.03M 91.90M 74.44M
Total operating expenses 79.54M 106.91M 96.48M 127.98M 179.38M
Cost of revenue 87.45M 87.05M 75.15M 79.94M 91.97M
Total other income expense net 0.42M 113.01M 11.10M -18.55M -403.92M
Discontinued operations - - - - -0.50M
Net income from continuing ops -2.93M 40.02M -70.44M -168.73M -396.70M
Net income applicable to common shares - 41.08M -73.96M -168.73M -396.11M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1194.96M 1166.31M 1140.09M 1213.01M 1397.74M
Intangible assets 8.87M 11.13M 21.08M 26.70M 18.08M
Other current assets 8.33M 6.28M 5.41M 7.11M 8.97M
Total liab 54.08M 55.33M 43.96M 72.05M 63.46M
Total stockholder equity 1091.91M 1064.06M 1099.57M 1143.88M 1337.24M
Other current liab 36.14M 0.04M 0.10M 55.62M 40.44M
Common stock 661.78M - 613.73M 611.32M 595.50M
Capital stock 662.98M 669.88M 613.73M 611.32M 595.50M
Retained earnings 446.94M 457.71M 416.72M 490.68M 659.42M
Other liab - - - 1.38M 1.99M
Good will 66.36M 63.45M 1.06M 1.03M 1.10M
Other assets - - - 0.19M 80.73M
Cash 790.35M 858.80M 669.29M 764.64M 886.97M
Cash and equivalents - - - 764.64M 886.97M
Total current liabilities 48.10M 49.70M 41.40M 68.12M 54.37M
Current deferred revenue - - 28.17M - -
Net debt -787.68M - -666.74M -760.77M -877.17M
Short term debt 0.34M - 0.99M 1.33M 2.71M
Short long term debt total 2.68M - 2.55M 3.88M 9.81M
Other stockholder equity - - 48.45M 42.68M 32.47M
Property plant equipment - - - 62.83M 82.95M
Total current assets 942.37M 936.11M 933.31M 960.16M 1079.72M
Long term investments 7.66M 2.81M 54.74M 89.75M 135.16M
Net tangible assets - - - 1116.15M 1318.07M
Short term investments 39.93M 0.00M 192.24M 113.08M 117.68M
Net receivables 57.09M 15.46M 35.88M 37.77M 33.29M
Inventory 46.66M 33.15M 30.50M 37.56M 32.80M
Accounts payable 11.62M 16.97M 12.13M 11.16M 11.22M
Accumulated other comprehensive income -16.81M - 20.68M -0.80M 49.87M
Non currrent assets other - - 0.04M 72.54M 80.73M
Non current assets total 252.59M 230.07M 206.78M 252.85M 318.02M
Capital lease obligations 1.51M 2.02M 2.55M 3.88M 9.81M
Long term debt total - - - 0.00M 0.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -45.11M 175.15M -59.50M -1.84M -19.41M
Change to liabilities - - - -0.86M -2.37M
Total cashflows from investing activities -77.90M 175.15M -59.50M -1.84M -28.90M
Total cash from financing activities -20.25M -1.23M -1.03M -2.90M -13.44M
Change to operating activities - - - -2.76M 1.97M
Net income -9.61M 40.02M -74.55M -168.73M -397.20M
Change in cash -109.07M 189.51M -95.35M -122.33M -191.05M
Begin period cash flow 899.42M 669.29M 764.64M 886.97M 1078.02M
End period cash flow 790.35M 858.80M 669.29M 764.64M 886.97M
Total cash from operating activities 26.32M 18.84M -42.84M -88.95M -153.62M
Depreciation 14.48M 9.34M 8.11M 13.12M 15.40M
Other cashflows from investing activities - -4.25M 18.61M 3.19M -16.64M
Change to inventory -10.58M 7.42M 7.40M -7.22M 11.56M
Change to account receivables -26.20M -2.51M 9.21M -2.71M -13.16M
Sale purchase of stock -9.91M - -1.36M - 0.02M
Other cashflows from financing activities -10.34M -1.23M -1.03M -2.90M -13.44M
Change to netincome - - - 46.00M 229.09M
Capital expenditures 26.17M 13.15M 3.42M 5.03M 12.26M
Change in working capital -35.02M -0.31M -26.47M 20.66M -2.00M
Stock based compensation 7.05M 8.70M 8.77M 15.12M 10.15M
Other non cash items 56.47M -38.90M -2.01M 30.89M 220.04M
Free cash flow 0.15M 5.69M -46.26M -93.98M -165.88M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CRON
Cronos Group Inc
0.16
3.36%
4.92 - 32.15 9.80 0.95 1.47 1.90
CURA
Curaleaf Holdings Inc.
-0.74
5.20%
13.49 - 138.89 2.57 3.14 2.47 13.10
BHC
Bausch Health Companies Inc
0.31
2.72%
11.72 13.98 1.35 0.28 18.74 2.12 6.84
TLRY
Tilray Inc
0.41
11.02%
4.13 - 1000.00 1.28 0.53 1.08 -2.30
GUD
Knight Therapeutics Inc.
0.02
0.18%
11.28 - 48.54 1.64 0.96 1.60 11.97

Profile*

Cronos Group Inc

Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.

4491 Concession Road 12, Stayner, ON, Canada, L0M 1S0

416 504 0004

610

Name Title Year Born
Mr. Michael Ryan Gorenstein J.D. Pres, CEO & Chairman 1987
Ms. Shannon Buggy Sr. VP & Global Head of People 1970
Ms. Anna Shlimak Sr. VP of Corp. Affairs & Strategy 1986
Mr. James Holm Chief Financial Officer NA
Mr. Carlos Cortez VP, Controller & Principal Accounting Officer 1973
Mr. Shayne J. Laidlaw Director of Investor Relations & Strategy NA
Mr. Terry Gregory-Joseph Doucet Sr. VP of Legal & Regulatory Affairs and Corp. Sec. 1990
Mr. Jeffrey David Jacobson Chief Growth Officer 1986
Mr. Arye Weigensberg Head of R&D NA
Mr. Kevin B Gifford VP of Fin. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…